Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: A systematic review and meta-analysis

Published:2019-04 Issue:4 Volume:51 Page:489-495
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Chokesuwattanaskul Ronpichai^ORCID,Thongprayoon Charat,Bathini Tarun,Torres-Ortiz Aldo,O’Corragain Oisin A.,Watthanasuntorn Kanramon,Lertjitbanjong Ploypin,Sharma Konika,Prechawat Somchai,Ungprasert Patompong^ORCID,Kröner Paul T.^ORCID,Wijarnpreecha Karn^ORCID,Cheungpasitporn Wisit

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference40 articles.

1. Venous thromboembolism with chronic liver disease;Saleh;Am J Med,2011

2. Regression of human cirrhosis: an update, 18 years after the pioneering article by Wanless et al;Hytiroglou;Virchows Arch,2018

3. The coagulopathy of chronic liver disease;Tripodi;N Engl J Med,2011

4. Hemostatic abnormalities and liver diseases;Wada;Semin Thromb Hemost,2008

5. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 study;Chugh;Circulation,2014

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH;Journal of Thrombosis and Haemostasis;2024-09

2. Direct oral anticoagulants in cirrhosis: Rationale and current evidence;JHEP Reports;2024-08

3. Safety of DOACs in patients with Child‐Pugh Class C cirrhosis and atrial fibrillation;JGH Open;2024-05

4. Assessing Safety of Anticoagulation for Atrial Fibrillation in Patients with Cirrhosis: A Real-World Outcomes Study;Journal of Cardiovascular Pharmacology and Therapeutics;2024-01

5. Efficacy and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients with Non-valvular Atrial Fibrillation and Liver Cirrhosis;2023-12-06